AnyBody Technology A/S Revenue and Competitors
Estimated Revenue & Valuation
- AnyBody Technology A/S's estimated annual revenue is currently $4.9M per year.
- AnyBody Technology A/S's estimated revenue per employee is $128,000
Employee Data
- AnyBody Technology A/S has 38 Employees.
- AnyBody Technology A/S grew their employee count by 73% last year.
AnyBody Technology A/S's People
Name | Title | Email/Phone |
---|
AnyBody Technology A/S Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.6M | 104 | 96% | N/A | N/A |
#2 | $8.4M | 58 | 35% | N/A | N/A |
#3 | $8.5M | 59 | 26% | N/A | N/A |
#4 | $7.9M | 55 | 28% | N/A | N/A |
#5 | $8.9M | 62 | 82% | N/A | N/A |
#6 | $8.2M | 57 | 30% | N/A | N/A |
#7 | $15.5M | 97 | 24% | N/A | N/A |
#8 | $100.4M | 502 | 20% | N/A | N/A |
#9 | $8.5M | 59 | 40% | N/A | N/A |
#10 | $7.6M | 53 | 23% | N/A | N/A |
What Is AnyBody Technology A/S?
AnyBody Technology develops and markets the #1 CAE software for musculoskeletal biomechanics.\nAnyBody Technology also provides consultancy, training courses and technical support to users and services clients. \n\nThe AnyBody Modeling System is a breakthrough invention for simulating body-device, man-machine or other man-environment interaction and how it effects the human body. \n\nKey markets for the products and the services of AnyBody Technology are the global orthopaedics, automotive, aerospace, assistive devices, and sports equipment industries. Users of the AnyBody Modeling System are mainly involved in either university research, or R&D activities in the industries.
keywords:N/AN/A
Total Funding
38
Number of Employees
$4.9M
Revenue (est)
73%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 41 | 32% | N/A |
#2 | $7.1M | 43 | 105% | N/A |
#3 | $5.9M | 46 | -21% | N/A |
#4 | $6.8M | 50 | -4% | N/A |
#5 | $7.5M | 53 | 8% | N/A |